Apollo Medical Holdings stock price, funding rounds, valuation and financials

Apollo Medical Holdings annual revenue was $560.62 m in FY 2019

$140.9 M

Apollo Medical Holdings Revenue Q2, 2020
Apollo Medical Holdings Cash, 30-Jun-2020152.4 M

Apollo Medical Holdings Revenue

Apollo Medical Holdings revenue was $560.62 m in FY, 2019

Embed Graph

Apollo Medical Holdings Funding

Apollo Medical Holdings Income Statement

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Revenue

2.6m2.6m4.1m11.7m10.2m11.4m10.7m12.4m14.6m15.7m41.6m40.5m124.2m123.0m167.3m95.8m130.0m156.1m165.1m140.9m

Cost of goods sold

2.4m2.1m3.3m6.2m7.6m8.3m8.5m10.1m12.2m12.7m40.2m39.1m84.7m99.5m96.8m83.4m101.4m131.1m144.2m

Gross profit

226.7k464.6k834.6k5.5m2.6m3.1m2.2m2.2m2.5m3.0m1.3m1.4m39.5m23.5m70.5m12.3m28.7m24.9m20.9m

Gross profit Margin, %

9%18%20%47%26%27%21%18%17%19%3%3%32%19%42%13%22%16%13%

General and administrative expense

1.6m1.3m2.0m3.5m4.2m3.4m3.5m3.8m4.5m4.5m4.9m5.3m11.7m11.5m9.0m10.3m11.8m7.9m11.8m

Operating expense total

1.6m1.3m2.0m9.8m4.3m3.5m12.1m4.0m4.6m4.6m5.0m5.5m16.8m16.4m13.9m15.6m14.0m14.9m16.5m

Depreciation and amortization

6.4k6.5k11.9k193.3k63.8k77.7k145.6k164.7k170.6k148.9k155.3k155.9k5.1m4.9m4.8m4.4m4.5m4.9m

EBIT

(1.4m)(813.5k)(1.2m)1.9m(1.7m)(412.9k)(1.5m)(1.8m)(2.2m)(1.7m)(3.7m)(4.1m)22.7m7.1m56.6m(3.3m)14.7m10.1m4.4m

EBIT margin, %

(52%)(31%)(29%)16%(16%)(4%)(14%)(14%)(15%)(11%)(9%)(10%)18%6%34%(3%)11%6%3%

Interest expense

170.8k169.2k276.9k329.3k473.1k67.1k101.0k821.5k518.6k290.9k154.3k145.0k244.8k2.2m3.4m550.5k144.6k4.4m

Interest income

9.5k32.5k269.8k339.8k343.4k323.0k473.7k508.9k929.0k

Investment income

(28.0k)1.7m(4.2m)(849.7k)(42.3k)2.1m2.1m

Pre tax profit

(1.5m)(982.7k)(1.5m)1.6m(2.1m)(480.0k)(1.5m)(940.9k)(1.7m)(1.4m)(3.9m)(4.3m)22.9m9.4m53.2m(3.9m)14.9m14.4m4.6m

Income tax expense

32.0k11.6k87.0k92.7k(186.1k)36.2k(41.6k)(185.0k)99.5k(29.9k)(26.9k)7.2m1.5m14.6m(1.4m)4.2m3.7m1.6m

Net Income

(1.5m)(1.0m)(1.7m)1.5m(2.5m)(531.4k)(1.5m)(1.3m)(1.4m)(1.7m)(3.6m)(3.9m)2.2m2.7m9.1m139.7k3.5m3.7m3.0m

Apollo Medical Holdings Balance Sheet

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Cash

1.3m1.0m5.8m4.0m7.0m3.9m3.9m4.6m6.5m3.8m4.0m31.2m30.2m103.7m101.1m119.8m93.0m52.7m230.3m80.9m152.4m

Accounts Receivable

1.4m1.5m1.5m3.4m3.5m3.7m4.0m3.7m4.0m4.6m6.0m5.4m4.9m52.8m34.5m70.1m6.6m16.7m19.7m18.0m17.6m

Prepaid Expenses

33.6k35.4k59.7k145.1k136.0k258.2k410.0k350.1k509.0k430.3k499.2k282.7k298.5k3.5m6.6m4.2m8.0m10.1m10.5m11.8m11.2m

Current Assets

2.8m2.6m7.8m13.4m10.7m8.2m8.7m9.2m11.4m9.1m10.8m37.7m35.7m180.6m152.8m202.8m176.9m167.6m321.4m318.1m380.5m

PP&E

66.9k62.4k99.2k620.0k560.9k577.3k577.7k1.2m1.3m1.3m1.3m1.2m1.1m13.7m13.3m12.9m12.3m12.1m12.4m

Goodwill

33.2k258.2k278.1k439.7k1.4m2.2m2.2m2.2m1.6m1.6m1.6m1.6m1.6m188.9m189.6m189.6m185.8m209.3m237.1m238.5m239.1m

Total Assets

3.1m3.2m8.8m16.1m15.0m13.3m13.6m14.6m17.3m15.0m16.8m43.3m41.2m521.6m511.0m551.9m520.9m568.3m750.2m724.4m833.2m

Accounts Payable

994.2k968.5k1.5m3.8m2.6m4.1m4.9m3.7m4.3m4.5m7.8m16.2m7.0m3.4m3.6m4.3m4.8m4.8m4.4m7.7m10.4m

Dividends Payable

3.8m271.3k337.0k431.0k

Short-term debt

394.3k25.0k25.0k5.5m378.2k260.9k9.5m12.6m12.9m

Current Liabilities

2.2m2.1m3.1m5.9m6.3m16.8m17.4m6.8m6.9m6.8m10.2m40.8m42.7m110.6m89.1m92.2m88.4m78.3m105.2m106.6m152.5m

Long-term debt

5.3m5.3m5.0m593.9k18.6m18.5m6.5m11.9m245.3m246.1m248.2m

Non-Current Liabilities

49.8m51.1m49.4m37.6m84.3m276.6m262.4m261.9m

Total Debt

2.2m5.3m5.3m5.0m394.3k25.0k25.0k6.1m18.9m18.8m6.5m11.9m9.5m258.7m261.1m

Total Liabilities

4.4m4.3m11.8m16.6m16.5m17.0m17.6m9.8m9.7m9.2m11.1m46.6m48.5m160.5m140.2m141.6m126.0m162.7m381.8m369.0m414.4m

Common Stock

35.9k38.0k49.1k49.1k48.6k4.9k4.9k5.5k6.0k6.0k6.0k6.0k6.1k32.7k32.8k33.0k34.5k34.6k34.8k36.0k36.0k

Preferred Stock

Additional Paid-in Capital

12.8m13.9m15.2m16.2m16.3m16.6m16.7m19.4m23.9m24.2m25.9m26.6m26.8m160.7m162.0m162.8m163.0m163.9m165.5m161.1m164.0m

Retained Earnings

(13.4m)(14.4m)(18.0m)(16.6m)(18.3m)(21.8m)(22.4m)(24.0m)(30.0m)(31.4m)(33.1m)(41.3m)(45.1m)4.9m7.6m17.1m17.9m21.5m25.2m36.0m43.0m

Total Equity

(1.3m)(1.0m)(3.0m)(504.0k)(1.5m)(3.7m)(4.0m)(2.3m)503.8k(1.3m)5.7m(3.3m)(7.3m)170.5m174.8m185.1m182.4m186.1m192.2m198.0m207.8m

Debt to Equity Ratio

-2.1 x0 x

Debt to Assets Ratio

0.7 x0 x

Financial Leverage

-2.5 x-3.1 x-2.9 x-31.9 x-10.2 x-3.6 x-3.4 x-6.3 x34.4 x-11.7 x2.9 x-13 x-5.6 x3.1 x2.9 x3 x2.9 x3.1 x3.9 x3.7 x4 x

Apollo Medical Holdings Cash Flow

Quarterly

USDQ2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020

Net Income

(2.4m)(3.4m)(1.7m)28.4k(1.4m)(2.2m)(2.5m)(4.1m)(899.4k)(2.4m)(3.9m)(3.8m)(8.1m)15.7m23.6m62.2m(2.5m)8.2m19.0m3.0m84.0m

Depreciation and Amortization

13.0k176.5k11.9k267.5k491.2k93.7k188.2k364.8k202.6k373.1k522.1k208.9k418.5k5.1m10.0m14.8m4.4m8.9m13.8m5.0m9.3m

Accounts Receivable

156.5k106.5k4.3k(993.7k)(850.8k)108.8k(214.1k)(49.1k)(774.1k)(1.3m)(2.8m)76.2k559.3k(21.1m)(2.8m)(38.4m)487.0k587.6k1.9m(7.0m)(6.3m)

Accounts Payable

43.5k17.9k(4.8k)2.2m607.0k790.6k1.6m371.9k(317.5k)(27.6k)3.2m8.3m(841.3k)(1.2m)(692.0k)31.7m22.6m3.3m4.9m(7.2m)(3.0m)

Cash From Operating Activities

(298.3k)(928.7k)(1.1m)(2.1m)652.3k(528.3k)(328.8k)(1.8m)(2.3m)(4.4m)(4.2m)22.6m21.5m4.7m13.4m31.9m(4.0m)(22.0m)10.1m(9.3m)12.6m

Purchases of PP&E

(11.8k)(13.9k)(12.0k)(15.6k)(37.2k)(42.6k)(166.0k)(163.5k)(205.8k)(259.6k)(36.1k)(56.4k)(485.1k)(682.7k)(867.7k)(103.6k)(376.4k)(806.6k)(269.0k)(451.0k)

Cash From Investing Activities

(11.8k)(113.9k)204.4k(2.0m)(2.7m)(42.6k)(166.0k)(163.5k)(205.8k)(494.6k)(36.1k)(56.4k)(489.1k)(20.3m)(20.2m)(111.8k)(50.2m)(60.4m)(943.0k)67.2m

Short-term Borrowings

(500.0k)(1.0m)(12.5k)(62.5k)(100.0k)(37.5k)(37.5k)

Long-term Borrowings

(500.0k)(500.0k)(24.4k)(49.0k)(73.8k)(25.2k)(50.5k)(76.0k)(2.4m)(2.4m)

Dividends Paid

(2.0m)(12.0m)(16.7m)(10.0m)(10.9m)(60.7m)(9.9m)(30.2m)

Cash From Financing Activities

385.8k878.2k(175.0k)1.2m2.1m(595.4k)(717.9k)1.6m(330.5k)(865.5k)(582.5k)(37.5k)48.0k(241.2k)(1.7m)(5.4m)(9.8m)21.6m173.7m(12.1m)(30.5m)

Net Change in Cash

75.7k(164.4k)(1.1m)(2.9m)120.3k(1.1m)(1.1m)(369.5k)(2.8m)(5.5m)(5.3m)22.5m21.5m4.0m(8.6m)6.2m(13.9m)(50.6m)123.4m(22.3m)49.2m

Interest Paid

96.7k161.2k150.5k356.2k514.2k101.0k380.7k499.0k7.1k10.2k13.1k584.0872.073.6k144.5k287.3k181.8k439.0k999.6k2.6m2.6m

Income Taxes Paid

9.4k41.4k11.1k18.6k18.6k32.2k32.2k94.0k16.4k16.4k13.7k17.6k17.7k11.6m18.0m16.7m17.9m

Apollo Medical Holdings Ratios

USDFY, 2012

Financial Leverage

-3.2 x